When I was diagnosed, all the talk was of Turning Point Therapeutics TPX-0131 4th generation TKI. That came to nothing during the trial. I have learned to be positive, but also have a healthy scepticism about early stage drug development. Nuvalent’s NVL-655 is I hope past the scepticism stage.